Trial Outcomes & Findings for Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants (NCT NCT01819064)

NCT ID: NCT01819064

Last Updated: 2023-04-06

Results Overview

incidence of bradycardia or other arrhythmias

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

60 participants

Primary outcome timeframe

five minutes

Results posted on

2023-04-06

Participant Flow

Participant milestones

Participant milestones
Measure
Children Weighing Less Than 15Kg
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure and weigh less than 15Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia. Atropine: IV dose at 5 mcg/kg
Overall Study
STARTED
60
Overall Study
COMPLETED
60
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Children Less Than 15Kg.
n=60 Participants
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure, and weighed less than 15Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia.
Age, Categorical
<=18 years
60 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Age, Continuous
6.5 months
n=5 Participants
Sex: Female, Male
Female
10 Participants
n=5 Participants
Sex: Female, Male
Male
50 Participants
n=5 Participants
Region of Enrollment
United States
60 participants
n=5 Participants
weight
8.1 kilograms
n=5 Participants

PRIMARY outcome

Timeframe: five minutes

Population: There was no restriction on enrollment so long as the child was \<15 kg.

incidence of bradycardia or other arrhythmias

Outcome measures

Outcome measures
Measure
Children Less Than 5Kg.
n=9 Participants
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure, and weighed less than 5Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia.
Children Weighing 5Kg to 15Kg
n=51 Participants
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure, and weighed between 5Kg and 15Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia.
Incidence of Bradycardia
0 participants
0 participants

Adverse Events

Children Less Than 15Kg.

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Children Less Than 15Kg.
n=60 participants at risk
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure and weigh less than 5Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia. Atropine: IV dose at 5 mcg/kg
Cardiac disorders
asystole
0.00%
0/60 • 1 day
until the child is discharged from hospital on the day anesthesia was provided
Cardiac disorders
Bradycardia
0.00%
0/60 • 1 day
until the child is discharged from hospital on the day anesthesia was provided

Other adverse events

Other adverse events
Measure
Children Less Than 15Kg.
n=60 participants at risk
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure and weigh less than 5Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia. Atropine: IV dose at 5 mcg/kg
Cardiac disorders
arrhythmias
0.00%
0/60 • 1 day
until the child is discharged from hospital on the day anesthesia was provided

Additional Information

Dr. Jerrold Lerman

Women and Children's Hospital of Buffalo, State University of New York at Buffalo

Phone: 7168787701

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place